glp-1 omaha Semaglutide for Weight Loss in Omaha, Nebraska | Imagen GLP-1 Program

When you hear units, thats just a way of measuring the dosage for injectionskind of like saying cups vs tablespoons when you cook

For patients with Graves disease who are not suitable candidates for tirzepatide or prefer alternative approaches, several evidence-based weight management options exist

Compare this to semaglutide results showing average losses of 10-15% body weight in clinical trials

The SUSTAIN trials demonstrated the non-inferiority of SMG as treatment for DM2, consistently reducing HbA1c levels and body weight with superior results compared to other standard therapies and significant cardiovascular benefits (SUSTAIN 6)

The same study found that semaglutide trials as a weight-loss drug exceeded the criterion set forth by both the FDA and EMA (European Medicines Agency) for obesity medications